COBRA: Copenhagen Obesity Risk Assessment Study

Sponsor
University of Copenhagen (Other)
Overall Status
Completed
CT.gov ID
NCT00655902
Collaborator
(none)
52
1
2
11
4.7

Study Details

Study Description

Brief Summary

The aim of the present study is to assess the effect of a high intake of industrially produced trans fatty acids for 16 weeks on abdominal obesity and risk markers of type 2 diabetes and heart disease in healthy, moderately overweight, postmenopausal women.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Trans fat (soy bean oil)
  • Dietary Supplement: Control fat (sunflower oil)
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
52 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Copenhagen Obesity Risk Assessment Study - A Double Blind Randomized Dietary Intervention Study Examining the Effect of a High Intake of Trans Fatty Acids on Abdominal Obesity and Risk Markers of Type 2 Diabetes and Cardiovascular Disease.
Study Start Date :
Apr 1, 2008
Actual Primary Completion Date :
Feb 1, 2009
Actual Study Completion Date :
Mar 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

Dietary Supplement: Trans fat (soy bean oil)
Industrially produced trans fatty acid from soy bean oil (15 g/d for 16 weeks). The fat (a total of 25 g/d) will be baked into buns.

Placebo Comparator: 2

Dietary Supplement: Control fat (sunflower oil)
Control fat from sunflower oil, with 60% oleic acid (in total 25 g/d for 16 weeks). The fat will be baked into buns.

Outcome Measures

Primary Outcome Measures

  1. change in LDL-cholesterol/LDL-cholesterol ratio [week 0, 8, 16 and 28]

  2. Change in Liver fat measured by MR-S [week 0, 16 and 28]

  3. Change in Insulin sensitivity (ISI composite) from 3h OGTT [week 0, 8, 16 and 28]

Secondary Outcome Measures

  1. Change in Waist circumference [week 0, 8, 16 and 28]

  2. Change in Visceral adipose tissue measured by MR [week 0, 16 and 28]

  3. Change in Intramuscular fat measured by MR-S (Psoas Major) [week 0, 16 and 28]

  4. Change in Body fat percentage measured by DEXA [week 0, 16 and 28]

  5. Change in 24h heart rate variability measured by Holter-monitoring [week 0, 16 and 28]

  6. Changes in Cytokines in blood [week 0, 8, 16 and 28]

  7. Changes in Cytokines in abdominal adipose tissue [week 0, 16 and 28]

  8. Changes in Ceramide in abdominal adipose tissue [week 0, 16 and 28]

  9. Changes in Metabolomic profile in blood and urine [week 0, 16 and 28]

Eligibility Criteria

Criteria

Ages Eligible for Study:
45 Years to 70 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age 45-70 years

  • BMI 25-32

  • Waist circumference > 80 cm

  • Postmenopausal for at least 1 year

Exclusion Criteria:
  • BP > 160/100 mmHg

  • Fasted blood glucose > 7 mM

  • Fasted LDL-cholesterol > 6 mM

  • Fasted triglycerides > 3 mM

  • Diabetes mellitus or other chronic diseases

  • Current or previous cardiovascular disease

  • Weight change > 3 kg within last 2 months

  • Use of anti-hypertensive drugs

  • Use of statins/fibrates

  • Use of fish oil supplements

  • Smoking

  • Hard physical activity > 10 h/week

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Human Nutrition, University of Copenhagen Frederiksberg Copenhagen Denmark 1958

Sponsors and Collaborators

  • University of Copenhagen

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00655902
Other Study ID Numbers:
  • B237
First Posted:
Apr 10, 2008
Last Update Posted:
Apr 29, 2011
Last Verified:
Apr 1, 2009

Study Results

No Results Posted as of Apr 29, 2011